1.0Allphase Pharma Consulting, LLChttps://allphasepharma.com/dirHaraldhttps://allphasepharma.com/dir/author/haraldeva/rich600338<blockquote class="wp-embedded-content" data-secret="ZxGsOuNRh2"><a href="https://allphasepharma.com/dir/2016/11/07/2862/profiling-solithromycin-fda-amdac-on-solithera/">Profiling Solithromycin: FDA AMDAC on Solithera</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://allphasepharma.com/dir/2016/11/07/2862/profiling-solithromycin-fda-amdac-on-solithera/embed/#?secret=ZxGsOuNRh2" width="600" height="338" title="“Profiling Solithromycin: FDA AMDAC on Solithera” — Allphase Pharma Consulting, LLC" data-secret="ZxGsOuNRh2" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script> /*! This file is auto-generated */ !function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document); //# sourceURL=https://allphasepharma.com/dir/wp-includes/js/wp-embed.min.js </script> https://i0.wp.com/allphasepharma.com/dir/wp-content/uploads/2016/11/Solithro-Pipe-Magritte.jpg?fit=640%2C180&ssl=1640180Police profiling based on race, sex or gender is a highly controversial practice. FDA doing the same, not so much. Profiling based on similarities to other drugs in the same category is nothing new. Class labeling can be expected for the next new B-lactam or quinolone regardless of whether during Continue reading →